Maha Katabi

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Joseph R. Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maha Katabi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 12,500 $204,625 $16.37 05 Jun 2024 Direct
RayzeBio, Inc. Director Common Stock 0 $0 $62.50 26 Feb 2024 Indirect
Vera Therapeutics, Inc. Director Stock Option (right to buy) 14,000 14 May 2025 Direct
RayzeBio, Inc. Director Series D Convertible Preferred Stock 0 19 Sep 2023 By Sofinnova Venture Partners XI, L.P.
RayzeBio, Inc. Director Series D Convertible Preferred Stock 0 19 Sep 2023 By Sofinnova Venture Partners X, L.P.
RayzeBio, Inc. Director Stock Option (right to buy) 0 26 Feb 2024 Direct

Insider Reports Filed by Maha Katabi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERA Vera Therapeutics, Inc. 14 May 2025 1 $0 4 Director 16 May 2025, 16:13
AVTE Aerovate Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 18:00
VERA Vera Therapeutics, Inc. 15 May 2024 1 $0 4 Director 17 May 2024, 16:13
VERA Vera Therapeutics, Inc. 21 Mar 2024 6 -$34,099,583 4 Director 25 Mar 2024, 21:46
RYZB RayzeBio, Inc. 26 Feb 2024 3 -$151,220,500 4 Director 27 Feb 2024, 16:47
VERA Vera Therapeutics, Inc. 30 Jan 2024 1 +$4,999,990 4 Director 01 Feb 2024, 17:58
AVTE Aerovate Therapeutics, Inc. 02 Jan 2024 1 +$47,471 4 Director, 10%+ Owner 04 Jan 2024, 18:00
RYZB RayzeBio, Inc. 17 Nov 2023 1 $0 4 Director 17 Nov 2023, 18:37
RYZB RayzeBio, Inc. 19 Sep 2023 6 +$8,499,996 4 Director 21 Sep 2023, 17:10
RYZB RayzeBio, Inc. 14 Sep 2023 0 $0 3 Director 14 Sep 2023, 19:27
AVTE Aerovate Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 18:00
VERA Vera Therapeutics, Inc. 10 May 2023 1 $0 4 Director 12 May 2023, 16:14
AVTE Aerovate Therapeutics, Inc. 03 Jan 2023 1 +$47,496 4 Director, 10%+ Owner 05 Jan 2023, 16:00
AVTE Aerovate Therapeutics, Inc. 21 Jun 2022 1 $0 4 Director, 10%+ Owner 22 Jun 2022, 17:00
VERA Vera Therapeutics, Inc. 24 May 2022 1 $0 4 Director, 10%+ Owner 26 May 2022, 16:11
AVTE Aerovate Therapeutics, Inc. 03 Jan 2022 1 +$47,494 4 Director, 10%+ Owner 05 Jan 2022, 16:15
AVTE Aerovate Therapeutics, Inc. 01 Jul 2021 4 +$5,027,488 4 Director, 10%+ Owner 06 Jul 2021, 16:27
AVTE Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Director, 10%+ Owner 29 Jun 2021, 19:42
VERA Vera Therapeutics, Inc. 18 May 2021 3 +$7,999,992 4 Director, 10%+ Owner 18 May 2021, 20:17
VERA Vera Therapeutics, Inc. 13 May 2021 1 $0 4 Director, 10%+ Owner 17 May 2021, 20:40
VERA Vera Therapeutics, Inc. 13 May 2021 0 $0 3 Director, 10%+ Owner 13 May 2021, 19:21
AVTE Aerovate Therapeutics, Inc. 01 Feb 2021 3 +$17,503,441 4 Director, 10%+ Owner 01 Jul 2021, 18:34